Clinical Trial Update: Risk Prediction of Dexmedetomidine-associated Hemodynamic Instability [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on predicting risk of dexmedetomidine-associated hemodynamic instability; study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation Disorders

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Sedation | Phase 2, Phase 3 | Status: SUSPENDED